Business Wire

Brilliant Start To Blue Port Hamburg: A Port Becomes a Stage

Jaa

It all began for Hamburg in 2006, when the FIFA World Cup took place in Germany. Light artist Michael Batz created “Blue Goals” – goal posts illuminated in blue, which public buildings, companies, and individuals used to decorate their roofs and show off their excitement about having the World Cup in their country. Hamburg then turned blue again in 2008, this time with the Blue Port Hamburg installation. This year, Michael Batz is bathing the port in blue light for the sixth time.

This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170906006432/en/

The internationally renowned light project Blue Port Hamburg once again transforms Hamburg’s night-t ...

The internationally renowned light project Blue Port Hamburg once again transforms Hamburg’s night-time port into a magically glowing stage (Photo: Business Wire)

A masterpiece in artistry and logistics

The preparations took an entire year, and the installation spans 8.5 kilometres along both sides of the Elbe. 50 kilometres of cable were laid down, and over 20,000 blue light elements were attached to buildings, industrial plants and ships within the Port of Hamburg. The highest point is the Elbphilharmonie, the new concert hall and landmark of the city, the roof of which now glows in blue light. Also involved in the installation are the “Speicherstadt and Kontorhausviertel” districts, which have been awarded UNESCO world heritage status 2015.

The installation does more than just light up the city with special effects, however. According to Batz, the installation should enable people to see their city in a new light and tell Hamburg’s urban story. “I want to use light to describe the fundamental structural change the port has seen – a port shaped by maritime activities, logistics and industry, which is increasingly developing into a multifaceted urban space with residential districts and culture.”

Hamburg turns blue for ten days

The official light-up ceremony of Blue Port Hamburg took place on Friday evening last week. The sensory experience will be beguiling both locals and visitors from all over the world until 10 September. The illuminated port will then take centre stage from 8 to 10 September, when the Hamburg Cruise Days are on. This event is the largest cruise festival in the world, with eleven major cruise liners and more than half a million visitors to the Port of Hamburg expected to attend.

Michael Batz has a particular way of describing the fascination that abounds: “The port – a place where everything that appears only has value once it disappears again. Light installations, which in their very nature are temporary, belong to this category. They glow and shine the brightest once the light has gone out. As fugitive reflectors of the world and of life in general, they mirror their darkest melancholy. And their deepest longing.”

http://www.hamburg.de/blue-port-hamburg/4333226/blue-port-art-project/

http://www.hamburgcruisedays.de/en/

Contact information

Press contact:
Red Roses PR
Katja Derow
+49 40 / 46 96 770 10
k.derow@redroses-pr.com

Tietoja julkaisijasta

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Tilaa tiedotteet sähköpostiisi

Haluatko tietää asioista jo ennen kuin ne uutisoidaan? Kun tilaat tiedotteemme tältä julkaisijalta, saat ne sähköpostiisi yhtä aikaa suomalaisen median kanssa. Tilauksen voit halutessasi perua milloin tahansa.

Lue lisää julkaisijalta Business Wire

Ipsen Receives Approval from European Commission for Xermelo® (Telotristat Ethyl) for the Treatment of Carcinoid Syndrome Diarrhea in Patients Inadequately Controlled by Somatostatin Analogue Therapy19.9.2017 19:00Tiedote

Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-driven biopharmaceutical group, today announced that the European Commission has approved Xermelo® (telotristat ethyl) 250 mg three times a day (tid) for the treatment of carcinoid syndrome diarrhea in combination with somatostatin analogue (SSA) therapy in adults inadequately controlled by SSA therapy. This approval allows for the marketing of Xermelo® (telotristat ethyl) in the above indication in all 28 member states of the European Union, Norway and Iceland. David Meek, Chief Executive Officer, Ipsen stated: “We are delighted to provide patients suffering from inadequately controlled carcinoid syndrome with a new treatment option in combination with a somatostatin analogue that demonstrates both efficacy and safety in particularly improving diarrhea, a most debilitating symptom. Xe

6th Annual World Patient Safety, Science & Technology Summit to Be Held in London, England19.9.2017 18:00Tiedote

The Patient Safety Movement Foundation (PSMF) announces that the 6th Annual World Patient Safety, Science & Technology Summit will take place in London on February 23-25, 2018. Rt. Hon. Jeremy Hunt MP, the Secretary of State for Health from England’s Department of Health, invited PSMF to hold its 6th annual Summit in London during his speech at the Summit in February of this year. This is the first time the Summit will be held outside of the United States. Over the years, the PSMF has taken an increasingly international scope to reach zero preventable patient deaths by 2020. They currently have over 30 Regional Chapters around the world and partnerships with global organizations such as the World Federation of Societies of Anaesthesiologists (WFSA), European Society of Anaesthesiology (ESA), Global Sepsis Alliance (GSA), the Taiwan Patient Safety Culture Club, Sistema Españo

Vertex Announces Upcoming Presentations of Data at 2017 North American Cystic Fibrosis Conference19.9.2017 17:50Tiedote

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that 11 abstracts from its cystic fibrosis (CF) research and development program will be presented at the annual North American Cystic Fibrosis Conference (NACFC) in Indianapolis, November 2 to 4, 2017. Previously announced data from the Phase 3 EVOLVE and EXPAND studies of the investigational tezacaftor/ivacaftor combination in people with CF ages 12 and older who have certain mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene will be presented for the first time. Additionally, data from the Phase 3 extension study of ORKAMBI® (lumacaftor/ivacaftor) in children with CF ages 6 to 11 who have two copies of the F508del mutation and real-world KALYDECO® (ivacaftor) data will be presented. The company also submitted an abstract for the late-breaking poster session with previously announced Phase 1

Biker Summer 2017 campaign: Last Chance to Win Great Prizes from Moto-tyres.co.uk19.9.2017 16:57Tiedote

Moto-tyres.co.uk wants to know: For the fifth year in a row, the online motorbike shop is asking bikers from ten European countries about their Biker Summer 2017 travel plans, favourite destinations and longest tours. For survey participants, Moto-tyres.co.uk and its sister shops in other European countries are raffling prizes to get every biker’s heart beating faster, including vouchers for new motorbike tyres, a GARMIN motorbike GPS navigation system, and a GoPro camera with helmet attachment. For more information and a link to the survey, go to: www.moto-tyres.co.uk/promotion-biker-summer-2017.html. The Biker Summer 2017 campaign is running until 30th September 2017 – so you still have time to join in and win top-quality equipment for your next bike tour. This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170919006105/en/

Andersen Global Expands into Uruguay19.9.2017 16:30Tiedote

Andersen Global announces its expansion into Uruguay through a Collaboration Agreement with Fischer & Schickendantz, one of the country’s leading law firms. The addition of Fischer & Schickendantz continues Andersen Global’s expansion and robust presence within the Latin American region. The team is led by Managing Partner, Juan Federico Fischer. “The addition of Juan Federico and the individuals at Fischer & Schickendantz bring a new depth to our team and our business development efforts in South America, while allowing us to deliver additional services in the region,” said Andersen Tax CEO, Mark Vorsatz. “Uruguay is the next major step in our firm’s growth and is an excellent complement for Andersen Global. The ability to provide a full scope of services in Uruguay offers significant advantages, especially given their large cross border client base and Uruguay’s increase

Horizon Petroleum Enters into Definitive Agreements to Acquire Concessions in Poland19.9.2017 16:05Tiedote

Horizon Petroleum Ltd. (the “Company” or “Horizon”) (TSXV:HPL) is pleased to report that further to its press releases dated June 23, 2017, and July 26, 2017, it has entered into a series of definitive agreements (the “Agreements”) with Dublin-based San Leon Energy plc (“SLE”) regarding the purchase from wholly-owned subsidiaries of SLE and other SLE-controlled entities, of 100% interests in 2 oil & gas concessions in the Republic of Poland known as Cieszyn and Bielsko-Biala (the “Primary Concessions”), plus 100% working interests in 2 additional oil & gas concessions in Poland known as Prusice and Kotlarka, and another concession which is under application (together the “Secondary Concessions”). These concessions cover 3,030km2 and lie within the prolific Rotliegendes Basin and Carpathian Foldbelt, where Horizon intends to target undeveloped conventional natural gas discoveries. Gas infr

Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.

Tutustu uutishuoneeseemme